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Background/aim: To examine changes in paratracheal lymph nodes (PLNs) and the relationship with the course of the disease in
patients with chronic autoimmune thyroiditis (CAT) 5 years after diagnosis.
Materials and methods: A total of 169 patients with newly diagnosed CAT and 53 healthy subjects were included in the study. All
patients underwent ultrasonographic (US) examinations of the thyroid, paratracheal regions, and examined thyroid function tests.
Eighty-four patients who were euthyroid at baseline and who were contacted 5 years after the diagnosis were reevaluated by US and
thyroid function tests.
Results: The PLNs frequency was significantly higher in the CAT group than the controls (75.1 % vs. 30.1 %, P < 0.001). Among
the 84 patients who were euthyroid at the time of diagnosis and were contacted again after 5 years, 15 developed hypothyroidism.
Initially, PLNs were present in all patients who developed hypothyroidism and were significantly higher than in those who remained
euthyroid (respectively 100% vs. 68.7%, P = 0.009). PLN presence and PLN volume in patients who were euthyroid at baseline predicted
hypothyroidism at the end of 5 years.
Conclusion: PLNs may be used as an indicator of disease progression. In addition, patient age and baseline TSH levels are other factors
that predict the development of hypothyroidism in time.
Key words: Chronic autoimmune thyroiditis, paratracheal lymph nodes, ultrasonography, antithyroid antibodies, hypothyroidism

1. Introduction
Chronic autoimmune thyroiditis (CAT) has a high
prevalence in the general population (1,2). The diagnosis
of CAT is usually based on clinical findings, positive
antithyroperoxidase antibody (TPOAb) or cytological
results and appearance on thyroid ultrasonography (US)
(3). However, none of the laboratory tests seem to be
ideal. The validity of using reduced thyroid echogenicity
as a predictor of possible CAT, in general, was very good.
However, the rate of diagnostic verification seems to
be lower when the history of thyroid disease is brief or
when the reduction in thyroid echogenicity is mild (4).
It is now known that not only the thyroid gland but also
the peripheral lymph nodes (LNs) contain lymphoid
follicles in autoimmune thyroid diseases (5–7). While LNs
* Correspondence: gulhanakcil@yahoo.com.tr

identified in CAT patients were previously thought to be
malignant, it has been understood that the LNs in CAT
patients are inflammatory (8,9). Paratracheal lymph nodes
(PLNs) are seen commonly in patients with autoimmune
thyroiditis. However, no study has examined the effects of
PLNs on the course of CAT.
In the current study, we aimed to investigate the
changes in PLNs and the relationship with the course of
the disease in CAT patients 5 years after diagnosis.
2. Materials and methods
This study was undertaken in the outpatient endocrinology
clinic between January 2008 and January 2009, with the
approval of the local ethics committee. A total of 169
consecutive patients with newly diagnosed thyroiditis (40.3
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± 12.2 years, males/females 9/160) and 53 healthy subjects
(35.5 ± 8.9 years, males/females 6/47) were included in the
study. For the control group, we selected 53 healthy subjects
with no clinical, laboratory (thyroid stimulating hormone
(TSH), TPOAb, TgAb, leukocyte count, C-reactive protein,
and erythrocyte sedimentation rate) and ultrasonographic
evidence of thyroid diseases or other neck diseases. All
patients underwent US examination of the thyroid and
paratracheal regions (Figure). All patients underwent
thyroid function tests, TPOAb, and antithyroglobulin
antibody (TgAb). Diagnosis of CAT was based upon the
presence of parenchymal hypoechogenicity (compared to
adjacent muscle structures) in conjunction with elevated
levels of TPOAb and/or TgAb. Patients who had a thyroid
nodule, clinical evidence of nonthyroidal benign diseases
of the neck and head, or a positive history of other
autoimmune systemic or other systemic diseases involving
lymphoid tissue were excluded. Previous amiodarone,
interferon, IL-2 therapy was added as a criterion for
exclusion.
To examine the effect of PLN presence on CAT course,
84 patients out of 97 euthyroid patients at diagnosis
were reevaluated 5 years later and they underwent US
examination of the thyroid and paratracheal regions, and
thyroid function tests were repeated.
2.1. Ultrasonography
Thyroid US was performed and interpreted by the
same experienced physicians (GA, SI), using the same
equipment with an 11 MHz linear transducer (Logiq 3 Pro,

GE Medical Systems, Milwaukee, WI, USA). The subjects
were examined in the supine position with hyperextended
neck. Images were obtained in the transverse and
longitudinal planes. The sizes of each lobe were measured,
and the volume was calculated by the mean of the elliptical
shape volume formula (π/6 × length × width × depth).
The paratracheal region is limited laterally by the carotid
vessels, posteriorly by the cervical musculature on the
right and the esophagus on the left, anteriorly by the
strap muscles, and inferiorly by the arterial and venous
brachiocephalic trunks. For each PLN we recorded the
following: long-axis diameter (expressed in mm); shortaxis diameter (defined as the widest diameter of the node
in the axial plane perpendicular to the long-axis diameter;
expressed in mm); long-axis diameter/short-axis diameter
ratio (L/S ratio).
2.2. Laboratory tests
Serum TSH level was evaluated using an Abbott
ARCHITECT 2000 device and the chemiluminescence
microparticle immunoassay (CMIA). Serum TgAb and
TPOAb values were evaluated by immunoradiometric
assay (IRMA) methods (ICN Pharmaceuticals, USA).
Normal ranges in our laboratory are as follows: TSH 0.35–
4.94 μIU/mL; TgAb < 50 IU/mL and TPOAb < 10 IU/mL).
Patients with TSH > 4.94 were considered hypothyroid.
2.3. Statistical analysis
Data analysis was performed using SPSS for Windows,
version 11.5 (SPSS Inc., Chicago, IL, USA). Whether the

Figure. Ultrasonographic imaging of thyroid and paratracheal region.
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distributions of continuous variables were normal or not
was determined by Kolmogorov–Smirnov test. Data were
shown as mean ± SD or number of cases and percentages,
where applicable.
While the differences in normally distributed data
between the CAT and control groups were evaluated by
Student’s t-test, the Mann–Whitney U test was applied for
the comparisons of not normally distributed variables.
Nominal data were analyzed by Pearson’s chi-square
or Fisher’s exact test, where appropriate. Whether the
differences between baseline and final thyroid volume,
number and volume of PLNs within CAT group were
statistically significant or not was evaluated by Wilcoxon’s
signed rank test. Degrees of association between
continuous variables were analyzed by Spearman’s rank
correlation test.
A P value less than 0.05 was considered statistically
significant.
3. Results
3.1. Results of baseline characteristics
Characteristics of the patients and controls are provided in
Table 1. TSH, TPOAb, and TgAb were significantly higher
in the CAT group compared to the controls (P < 0.001 for
all). At the time of diagnosis, thyroid volume was higher in
the CAT group compared to the controls but did not differ
significantly (P = 0.201).
PLNs were significantly more common in the CAT
group compared to the controls (75.1% vs. 30.1%, P <
0.001) (Table 2). Numbers of PLNs were comparable
between the subjects in the control and CAT groups in
whom LNs were detected (P = 0.072), and the CAT group
had significantly higher PLN volume compared to the
controls (P = 0.022).
Although both long and short LN sizes were greater in
the CAT group compared to the controls (9.6 ± 5.3 mm vs.

6.6 ± 3.0 mm, P = 0.010; 5.0 ± 1.4 mm vs. 3.9 ± 1.3 mm, P =
0.046), the ratio of long versus short sizes was statistically
comparable between the groups (P = 0.455) (Table 2).
The TSH, TPOAb, and TgAb levels were similar at the
time of diagnosis between the PLN positive and negative
CAT patients [respectively 3.5 ± 2.2 vs. 3.5 ± 2.3, P = 0.888;
141.7 (0.04–1087) vs. 46.4 (0–910), P = 0.104; and 88.5
(0.1–4000) vs. 26.6 (0–620), P = 0.06].
There was a statistically significant positive correlation
between TPOAb level and the number of PLNs (r =
0.256 and P < 0.001), whereas no statistically significant
correlation was found between the TgAb level and the
number of PLNs (r = 0.040 and P = 0.660). There was no
significant correlation between TSH and PLN numbers
(r = –0.104 and P = 0.245). No correlation was found
between PLN volumes and TSH, TPOAb, and TgAb levels
(respectively r = 0.07, P = 0.309; r = 0.04, P = 0.491; and r
= –0.009, P = 0.890).
PLN volume at diagnosis ≥0.085 cm3 predicts CAT
diagnosis with 82.3% sensitivity and 75.0% specificity
(AUC = 0.779, 95% CI = 0.590–0.969).
Initially, 97 patients were euthyroid and 72 patients
were hypothyroid. PLN was positive in 73.5% of the
euthyroid patients and PLN was present in 82% of the
hypothyroid patients, respectively, and were similar
between the 2 groups (P = 0.250).
3.2. Results of analyses 5 years after diagnosis
There was a statistically significant reduction in thyroid
volume from baseline at year 5 in the CAT group (P <
0.001) (Table 3). Five years after the diagnosis there was no
statistically significant difference in the number of PLNs (P
= 0.673) but statistically a significant decrease was found
in PLN volume (P < 0.001) in the CAT group.
Sixty-nine of the 84 euthyroid subjects that were able to
be reevaluated in the fifth year were still euthyroid while 15
developed hypothyroidism. In all patients, PLN presence

Table 1. Clinical and biochemical characteristics of chronic autoimmune thyroiditis and control groups.
Variables

CAT (n = 169)
(mean ± SD)

Control (n = 53)
(mean ± SD)

P-value

Age (year)

40.3 ± 12.2

35.5 ± 8.9

0.077†

Sex (male/female)

9 (5.3%)/160 (94.7%)

6 (11.3%)/47 (88.7%)

0.257

TSH (μIU/mL)

3.2 ± 2.3

1.91 ± 1.1

<0.001¶

TPOAb (IU/L)

196.78 ± 265.29

2.90 ± 2.38

<0.001¶

TgAb (IU/L)

210.15 ± 511.21

2.83 ± 2.55

<0.001¶

13.4 ± 9.03

11.6 ± 2.50

0.451¶

Thyroid volume (cm )
3

† Student’s t-test, ‡ Fisher’s exact test, ¶ Mann–Whitney U test.
CAT, chronic autoimmune thyroiditis; TSH, thyrotropin; TPOAb, antithyroperoxidase antibodies;
TgAb, antithyroglobulin antibodies; NS, not significant; SD, standard deviation.
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Table 2. Baseline US characteristics of paratracheal lymph nodes in chronic autoimmune thyroiditis and
control groups.
US characteristics

CAT (n = 169)
(mean ± SD)

Control (n = 53)
(mean ± SD)

P-value

Patients with PLNs

127 (75.1%)

16 (30.1%)

<0.001†

Number of PLNs

2.90 ± 2.36

1.50 ± 0.76

0.072‡

Volume of PLNs (cm3)

0.23 ± 0.45

0.07 ± 0.08

0.022‡

Long-axis diameter of PLNs (mm)

9.63 ± 5.27

6.56 ± 3.02

0.010‡

Short-axis diameter of PLNs (mm)

4.96 ± 1.35

3.87 ± 1.33

0.046‡

L/S ratio

1.95 ± 0.60

1.80 ± 0.77

0.455‡

† Pearson’s chi-square test, ‡ Mann–Whitney U test.
PLNs, Paratracheal lymph nodes; US, ultrasonography; L/S ratio, long-axis diameter/short-axis diameter
ratio.

Table 3. Comparison of the thyroid and paratracheal lymph node characteristics of the
patients with chronic autoimmune thyroiditis who were euthyroid at the time of diagnosis
and 5 years after the time of diagnosis (n = 84).
Baseline
(mean ± SD)

Variables

After 5 years
(mean ± SD)

P-value †

Thyroid volume (cm3)

5.62 ± 3.17

4.50 ± 3.46

<0.001

Number of PLNs

2.91 ± 1.71

3.19 ± 1.71

0.673

0.19 ± 0.12

0.06 ± 0.05

<0.001

Volume of PLNs (cm )
3

† Wilcoxon’s signed rank test.
PLNs, Paratracheal lymph nodes

in those who developed hypothyroidism was significantly
higher than in those who remained euthyroid (respectively
100% vs. 68%, P = 0.009) (Table 4). The volume of PLNs and
TPOAb and TgAb titers at the time of diagnosis of patients
who developed hypothyroidism at the end of year 5 was
higher compared to the group of patients who remained
euthyroid, although the groups differed significantly only
in TgAb (P = 0.181, P = 0.430, and P = 0.014, respectively).
The proportion of patients who remained euthyroid at
the end of year 5 did not differ significantly compared
to those who developed hypothyroidism at post-5 year
examinations of the number of PLNs (3.2 ± 2.1 vs. 2.5 ±
1.5, P = 0.106).
In regression analysis, when variables affecting
hypothyroidism development among CAT patients at 5
years were examined, age, TSH levels, and PLN volume
were found to be statistically significant (Table 5).
Age ≥ 42 years was found to predict hypothyroidism
with 61.5% and 58.5% sensitivity and specificity, while
TSH value ≥
 2.36 was found to predict hypothyroidism
with 61.5% sensitivity and 43.9% specificity, respectively.
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4. Discussion
It is now known that not only the thyroid gland but also the
peripheral LNs contain lymphoid follicles in autoimmune
thyroid diseases (5–7). Recent studies showed that LNs
observed in CAT patients had inflammatory character
(8,9).
In our study, PLN was more common in the CAT
group than in the control group and the long PLNs and
short PLNs, as well as their volumes, were greater in the
CAT group. Similar to the results of our study, a study
demonstrated more common PLN among CAT patients
compared to controls and the authors noted that they
considered these LNs to be of inflammatory nature
although they did not describe the long/short axis of the
LNs. The authors described that the optimal cutoff for
predicting CAT was the presence of more than 2 PLNs
larger than 7 mm (8). In our study PLN volume ≥ 0.085
cm3 was predictive of CAT with 82.3% sensitivity and
75.0% specificity.
The titer of TPOAb correlates well with the number of
autoreactive lymphocytes infiltrating the thyroid (10) and
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Table 4. Comparison of baseline diagnostic ultrasound and laboratory characteristics of patients who
were euthyroid with their thyroid function after 5 years.
Variables
PLNs (n, %)

Euthyroid (n = 69)

Hypothyroid (n = 15)

P-value

47 (68)

15 (100)

0.009

Volume of PLNs (cm )

0.13 ± 0.06

0.18 ± 0.15

0.181

TPOAb (IU/L)

158.70 ± 245.73

211.07 ± 163.62

0.430

TgAb (IU/L)

128.2 ± 323.2

479.5 ± 1033.3

0.014

3

Table 5. Effect of baseline laboratory and US features on hypothyroidism development at the end of 5 years in the CAT
group
Coefficientsa
Model

Unstandardized
coefficients

Standardized
coefficients

B

Beta

Std. error

t

Sig.

Constant

4.452

0.965

4.615

0.001

Age (years)

–0.028

0.010

–0.758

–2.781

0.019

TSH (μIU/mL)

–0.246

0.068

–0.749

–3.620

0.005

sT3 (pg/mL)

–0.144

0.164

–0.248

–0.877

0.401

sT4 (ng/dL)

0.415

0.356

0.222

1.164

0.272

Number of PLNs

–0.067

0.084

–0.235

–0.797

0.444

Volume of PLNs (cm3)

–2.841

1.359

–0.444

–2.090

0.043

TPOAb (IU/L)

–0.495

0.349

–0.443

–1.419

0.186

TgAb (IU/L)

0.261

0.426

0.196

0.611

0.555

the degree of sonographic hypoechogenicity, heterogeneity,
and pseudonodular hypoechoic infiltration (11). TPOAb
has been established to represent the current activity
of CAT and subsequent thyroid destruction because
the TPO-antigen is closely involved with cell-mediated
cytotoxicity, whereas the TgAb is not (12). Multiple
antigen configurations of thyroglobulin are produced
when it becomes iodinated, resulting in functionally active
but immunologically distinct molecules (13). The studies
failed to demonstrate a relation between sonographic
heterogeneity and TgAb levels (11,14). In our study,
there was no relationship between TgAb level and PLN
number. With the previously proven correlation with
disease activity and inflammatory response, TPOAb level
was positively correlated with the number of PLNs in our
study. This result supports the relationship between PLNs
and current inflammation of the thyroid tissue in CAT
patients. However, TgAb titer at the time of diagnosis was
more effective than TPOAb in predicting hypothyroidism
development during the course of CAT.

A recent study has demonstrated that the number of
cervical LNs with a long diameter of > 1 cm in levels II,
III, and IV and the axis of lymph nodes in levels III and IV
were higher in CAT patients compared to controls (9). The
authors think that the LNs with benignant hyperplastic
appearance detected mainly in levels II, III, and IV were
characteristics of CAT patients. In that study, PLN was
determined only in five CAT patients and statistical
analysis was not performed due to the limited number of
patients. In our study, we found that thyroid volume and
PLNs were significantly reduced at the 5-year follow-up.
PLN occurs in CAT when the inflammatory process is
active, with PLNs reducing in size with lengthening disease
duration and diminishing inflammation. Although the
disease duration of the five patients with identified PLN
was not reported, we are of the opinion that retrothyroidal
LNs were not identified because the patients for whom
PLNs were not identified had long disease durations.
All patients who were euthyroid at the time of
diagnosis but developed hypothyroidism at the end of
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year 5 were PLN-positive at the time of diagnosis. We
think that PLNs detected in CAT patients might reflect
not only the extent of current inflammation of the thyroid
tissue but also subsequent destruction in CAT. TPOAb
and TgAb titers at the time of diagnosis of patients who
developed hypothyroidism at the end of year 5 were
higher compared to patients who remained euthyroid
while only the TgAb difference was statistically significant.
TgAb-positive CAT patients may clinically present as
euthyroid, subclinical, or with overt hypothyroidism. The
role of TgAb in CAT progression is still not clear. Previous
studies have demonstrated that immunological properties
of TgAb such as immunoglobulin G subclasses (15), titers,
and avidity (16) might be involved in CAT. Another study
demonstrated that CAT patients with different thyroid
functional status exhibit different Tg epitope recognition
patterns (17). We found in our study that high TgAb
titer, TSH, age, PLNs presence, and PLNs volume at the
time of diagnosis were predictive of hypothyroidism
development during the course of CAT. Similar to our
results, a previous study has also reported that high titer
of TgAb and advanced age could be a possible predictor of
hypothyroidism in CAT (18).

Because healthy thyrocytes decrease over time, the
risk of developing hypothyroidism at the end of 5 years
is higher in CAT patients with high autoantibody levels,
a marker of significant inflammation, and PLNs on the
first examination. We are of the opinion that thyrocyte
reserves were partially adequate in CAT patients with
ongoing active inflammation, which we associated with
the presence of PLNs persisting over a period of 5 years,
and that these patients thus remained euthyroid after 5
years.
There are a limited number of publications on
sonographic features of LNs in CAT. To the best of our
knowledge, there is no study on the relationship of PLN
presence and CAT course. In conclusion, CAT patients
may present with inflammatory LNs, and PLNs might
reflect not only the extent of current inflammation of the
thyroid tissue but also subsequent destruction in CAT.
There were limitations to our study. Except for
PLN size, features such as cortical thickness, type of
vascularization, and contour of the lymph nodes were not
evaluated. The development of hypothyroidism in a small
number of patients in the 5th year is another limitation.
Further studies of detailed sonographic features of PLNs
with more patients are needed to clarify this subject.

References
1.

Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J
Med 2003; 348: 2646-2655.

2.

Vanderpump MP, Tunbridge WM, French JM, Appleton D,
Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H,
Tunbridge F et al. The incidence of thyroid disorders in the
community: a twenty-year follow-up of the Whickham Survey.
Clin Endocrinol (Oxf) 1995; 43: 55-68.

3.

Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis:
clinical and diagnostic criteria. Autoimmun Rev 2014; 13.pii:
S1568-9972(14)00019-6.

4.

Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking
O, Vik-Mo H. The value of ultrasonography in predicting
autoimmune thyroid disease. Thyroid 2000; 10: 251-259.

5.

Armengol MP, Juan M, Lucas-Martín A, Fernández-Figueras
MT, Jaraquemada D, Gallart T, Pujol-Borrell R. Thyroid
autoimmune disease: demonstration of thyroid antigen specific
B cells and recombination-activating gene expression in
chemokine-containing active intrathyroidal germinal centers.
Am J Pathol 2001; 159: 861-873.

6.

McIntosh RS, Asghar MS, Kemp EH, Watson PF, Gardas A,
Banga JP, Weetman AP. Analysis of immunoglobulin G kappa
antithyroid peroxidase antibodies from different tissues in
Hashimoto thyroiditis. J Clin Endocrinol Metab 1997; 82:
3818-3825.

1178

7.

McIntosh RS, Asghar MS, Watson PF, Kemp EH, Weetman
AP. Cloning and analysis of IgG kappa and IgG lambda
antithyroglobulin autoantibodies from a patient with
Hashimoto thyroiditis: evidence for in vivo antigen-driven
repertoire selection. J Immunol 1996; 157: 927-935.

8.

Serres-Creixams X, Castells-Fuste I, Pruna-Comella X,
Yetano-Laguna V, Garriga-Farriol V, Gallardo-Agromayor
E. Paratracheal lymph nodes: a new sonographic finding in
autoimmune thyroiditis. J Clin Ultrasound 2008; 36: 418-421.

9.

Brancato D, Citarrella R, Richiusa P, Amato MC, Vetro C,
Galluzzo CG. Neck lymph nodes in chronic autoimmune
thyroiditis: the sonographic pattern. Thyroid 2013; 23: 173177.

10.

Pandit AA, Vijay Warde M, Menon PS. Correlation of number
of intrathyroid lymphocytes with antimicrosomal antibody
titer in Hashimoto’s thyroiditis. Diagn Cytopathol 2003; 28: 6365.

11.

Willms A, Bieler D, Wieler H, Willms D, Kaiser KP, Schwab
R. Correlation between sonography and antibody activity in
patients with Hashimoto thyroiditis. J Ultrasound Med 2013;
32: 1979-1986.

12.

Sinclair, D. Clinical and laboratory aspects of thyroid
autoantibodies. Ann Clin Biochem 2006; 43: 173-183.

AKBABA et al. / Turk J Med Sci
13.

Terauchi M, Yanagawa T, Ishikawa N, Ito K, Fukazawa T,
Maruyama H, Saruta T. Interactions of HLA-DRB4 and CTLA4 genes influence thyroid function in Hashimoto’s thyroiditis
in the Japanese population. J Endocrinol Invest 2003; 26: 12081212.

14.

Wakita Y, Nagasaki T, Nagata Y, Imanishi Y, Yamada S, Yoda
K, Emoto M, Ishimura E, Inaba M. Thyroid heterogeneity,
as indicated by the CV of ultrasonographic intensities,
correlates with anti-thyroid peroxidase antibodies in euthyroid
Hashimoto’s thyroiditis. Thyroid Res 2013; 6: 5.

15.

Li MR, Guo XH, Gao Y. Distribution and significance of IgG
subclasses of serum antithyroglobulin antibody in Hashimoto
thyroiditis. Zhonghua Nei Ke Za Zhi 2008; 47: 121-124.

16.

Zhang Y, Gao Y, Li M, Xie L, Huang Y, Gao Y, Guo X. Avidity of
thyroglobulin antibody in sera from patients with Hashimoto’s
thyroiditis with different thyroid functional status. Clin Exp
Immunol 2010; 161: 65-70.

17.

Liu M, Zhao L, Gao Y, Huang Y, Lu G, Guo X. Epitope
recognition patterns of thyroglobulin antibody in sera from
patients with Hashimoto’s thyroiditis on different thyroid
functional status. Clin Exp Immunol 2012; 170: 283-290.

18.

Chou KM, Huang BY, Chen CH, Lin JD, Chiu SY, Lee CC.
Correlation and presentation of thyroid functional status with
thyroid autoantibodies in long-term follow-up of autoimmune
thyroiditis: A study of 116 cases. J Formos Med Assoc 2013;
Nov20.pii: S0929-6646(13)00370-7.

1179

